发明名称 |
Treatment of obesity and essential hypertension and related disorders. |
摘要 |
<p>The administration of antagonists and blockers of amylin or CGRP or both for the treatment of obesity and essential hypertension and associated lipid disorders and atherosclerosis.</p> |
申请公布号 |
EP0408294(A2) |
申请公布日期 |
1991.01.16 |
申请号 |
EP19900307502 |
申请日期 |
1990.07.10 |
申请人 |
AMYLIN CORPORATION |
发明人 |
COOPER, GARTH J.S.;LEIGHTON, BRENDAN |
分类号 |
A61K38/00;A61K38/22;A61K38/23;A61K39/00;A61K39/395;A61P3/06;A61P3/08;A61P9/10;A61P9/12;C07K16/26 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|